Bristol-Myers Squibb Foundation Joins White House Cancer Moonshot

$25MM in funding will expand scope of community-based cancer
treatment, care and support for underserved patients

NEW YORK–(BUSINESS WIRE)–Today the Bristol-Myers Squibb Foundation joins the White House Cancer
Moonshot initiative through its commitment to addressing health
disparities in cancer care. In response to the Cancer Moonshot, the
Foundation is committing $25 million in new funding to grantee partners
to expand the current scope of community-based resources and
survivorship support programs to underserved populations in the U.S. The
Cancer Moonshot is led by Vice President Joe Biden with a goal of making
a decade worth of advances in cancer prevention, diagnosis, and
treatment, in five years.

“The Vice President’s Moonshot Initiative is vitally important for
patients living with cancer and their families,” said Giovanni
, Bristol-Myers Squibb Chief Executive Officer and chairman
of the Bristol-Myers Squibb Foundation board of directors. “We are
dedicated to fighting cancer and are excited to join this collective
effort to defeat this deadly disease, once and for all.”

At the White House event, the Bristol-Myers Squibb Foundation announced
five partnership grants under this new commitment at the White House
Cancer Moonshot event: Project ECHO, American Cancer Society, University
of South Carolina College of Nursing, West Virginia University Cancer
Institute and the Mississippi Public Health Institute. The remaining
funding will be awarded over the next two years.

As part of the Cancer Moonshot commitment, the Foundation awarded a $10
million grant to Project ECHO (Extension for Community Healthcare
Outcomes), a multiyear initiative, to bring top-quality care to cancer
patients living in rural and underserved areas where cancer specialists
are not readily available and to improve cancer health outcomes through
pairing doctors at National Cancer Institute-designated Comprehensive
Cancer Centers and academic medical centers with those in community
hospitals and health centers. The Foundation will also fund the American
Cancer Society, University of South Carolina College of Nursing, West
Virginia University Cancer Institute and the Mississippi Public Health
Institute to develop, deliver and evaluate innovative models of
comprehensive, coordinated care that meet the needs of survivors of lung
cancer, their family members and caregivers. Each partner was awarded
$750,000 over two years to develop interdisciplinary, patient-centered
survivorship care services.

“Our mission to address health disparities strongly complements the
Moonshot goal of accelerating breakthroughs in cancer prevention,
treatment options and care,” says John Damonti, president of the
Bristol-Myers Squibb Foundation. “The projects we support specifically
focus on populations that are both underserved and at high risk for
cancer. Our aim is to develop best practices for strengthening clinic
and community cancer services and support systems so that breakthroughs
can benefit everyone.”

In addition to the funding commitment announced today, the Bristol-Myers
Squibb Foundation has since 2014, committed more than $27 million to 15
grantee partners to address disparities in access to cancer services and
health outcomes for vulnerable, low-income and medically underserved
people. Many of these grants were made under the Foundation’s Bridging
Cancer Care program that seeks to reduce the burden of lung cancer
through innovative models of prevention, detection and education, and by
helping people living with lung cancer access and navigate cancer care
and community-based supportive services. Known as the Tobacco belt, the
region of focus is the southeastern states with the highest lung cancer
and mortality rates in the U.S. – Kentucky, Tennessee, West Virginia,
North and South Carolina, Alabama and Mississippi.

In 2015, the Foundation launched a new initiative to address inequities
in access to specialty care services including cancer by vulnerable
populations in the U.S. The goal of this national initiative is to
catalyze sustainable improvement and expansion of specialty care service
delivery by safety net providers to achieve more optimal and equitable
outcomes for the people they serve with lung and skin cancer, as well as
other diseases.

About the Bristol-Myers Squibb Foundation

The mission of the Bristol-Myers Squibb Foundation is to promote health
equity and improve the health outcomes of populations disproportionately
affected by serious diseases and conditions, by strengthening
community-based health care worker capacity, integrating medical care
and community-based supportive services, and mobilizing communities in
the fight against disease. For more information about the Bristol-Myers
Squibb Foundation, please visit
or follow us on LinkedIn,
and Facebook.


Bristol-Myers Squibb Foundation
Lisa McCormick
Lavery, 609-252-7602